Listed

Koninklijke Philips NV: Form 20-F for the period ended Dec 31, 2017

Filed with the SEC on Feb 20, 2018 and accepted by EDGAR at Feb 20, 2018, 17:31 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2017-01-01 to 2017-12-31EUR 17.78bnifrs-full:Revenue
Cost of revenue12 months2017-01-01 to 2017-12-31EUR 9.60bnifrs-full:CostOfSales
Gross profit12 months2017-01-01 to 2017-12-31EUR 8.18bnifrs-full:GrossProfit
Operating income12 months2017-01-01 to 2017-12-31EUR 1.52bnifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2017-01-01 to 2017-12-31EUR 349.0mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2017-01-01 to 2017-12-31EUR 1.66bnifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2017-01-01 to 2017-12-31EUR 1.75ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2017-01-01 to 2017-12-31EUR 1.78ifrs-full:BasicEarningsLossPerShare
Capital expenditure12 months2017-01-01 to 2017-12-31−EUR 420.0mifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2017-12-31EUR 1.94bnifrs-full:CashAndCashEquivalents
Current assetsAt period end2017-12-31EUR 10.12bnifrs-full:CurrentAssets
Total assetsAt period end2017-12-31EUR 25.32bnifrs-full:Assets
Current liabilitiesAt period end2017-12-31EUR 6.87bnifrs-full:CurrentLiabilities
Shareholders' equityAt period end2017-12-31EUR 12.00bnifrs-full:EquityAttributableToOwnersOfParent
Shares outstandingAt period end2017-12-31926,191,723 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000313216-18-000007. Last ingested by Listed: Nov 3, 2026, 08:26 ET. Listed shows no prices and gives no investment advice.